淋巴管静脉吻合术后上肢淋巴水肿压迫治疗的减量与停止
本研究纳入30例继发性上肢淋巴水肿患者,评估淋巴管静脉吻合术(LVA)后按预设标准减少或停止压迫治疗的效果。结果显示早期患者50.0%可完全停止压迫治疗,晚期患者无完全停止者(p=0.0017),但50.0%晚期患者可实现部分减量;丹毒发生率从30.0%降至3.3%。
要点
- LVA术后早期淋巴水肿患者更可能完全停止压迫治疗。
- 晚期患者部分减量压迫治疗的比例为50.0%,无完全停止者。
- LVA术后丹毒发生率下降26.7%。
核心结论
- LVA与分期特异性的压迫治疗调整相关,早期患者更易完全停止压迫治疗,晚期患者更多实现部分减量。
研究设计与样本
- 纳入30例继发性上肢淋巴水肿接受LVA并随访至少一年的患者,其中14例2a期、14例2b期、2例3期。
主要发现
- 术后肢体周径平均减少4.5%±4.3%。
- 丹毒发生率下降26.7%(从30.0%降至3.3%)。
- 早期患者完全停止压迫治疗7例(50.0%),晚期患者0例(p=0.0017)。
- 部分减量仅见于晚期组(8/16,50.0%)。
关键数值与推荐
- 压迫治疗采用弹力袖套、手套和绷带,根据水肿严重程度应用。
- 术后确认改善和临床稳定后,按预设机构标准减少或停止压迫治疗。
临床怎么用
- LVA术后可根据分期制定压迫治疗减量或停止策略,早期患者可考虑完全停止,晚期患者以部分减量为目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymphaticovenular anastomosis (LVA) is known to reduce edema and prevent cellulitis in patients with lymphedema. However, standardized criteria for reducing or discontinuing compression therapy have not been established, and stage-specific outcomes remain unclear. Therefore, we investigated the efficacy of LVA in achieving partial reduction or complete discontinuation of compression therapy in patients with secondary upper extremity lymphedema. METHODS: We included 30 patients with secondary upper extremity lymphedema who underwent LVA and were followed for at least one year. Depending on the severity of edema, compression therapy was applied using elastic sleeves, gloves, and bandages. Compression therapy was reduced or discontinued according to predefined institutional criteria after postoperative improvement and clinical stability were confirmed. RESULTS: Among the 30 patients, 14 had stage 2a, 14 had stage 2b, and 2 had stage 3 lymphedema. The mean postoperative reduction in limb circumference was 4.5% ± 4.3%. The incidence of cellulitis decreased by 26.7% (from 30.0 to 3.3%). Complete discontinuation of compression therapy was achieved in 7 early-stage patients (50.0%) and in 0 advanced-stage patients (p = 0.0017). Partial reduction was observed exclusively in the advanced-stage group (8/16, 50.0%). CONCLUSION: LVA was associated with stage-specific modification of compression therapy. Early-stage patients are more likely to achieve complete discontinuation, whereas advanced-stage patients more likely achieved partial reduction. Furthermore, reduction in compression burden may contribute to improved quality of life. These findings support a stage-adapted treatment strategy for LVA in upper extremity lymphedema.
引用
- Tsukura K, Onoda S, Noto M, et al. Reduction and discontinuation of compression therapy after lymphaticovenular anastomosis for upper extremity lymphedema. J Plast Reconstr Aesthet Surg. 2026. PMID: 42600542. doi:10.1016/j.bjps.2026.07.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。